Sionna Corp (SION) - Bozor kapitallashuvining balans qiymatiga nisbati
Sionna Therapeutics Inc (SION) uchun asosiy muammo dori vositalarini sinovdan o'tkazishning erta bosqichlaridagi potentsial muvaffaqiyatsizliklar va sanoatning yirik ishtirokchilari tomonidan bosim ostida mablag'lar yetishmasligi bo'lib qolmoqda. Biroq, yuqori ishlab chiqish xarajatlari va patentlar yangi ishtirokchilar uchun kirishning mustahkam to'sig'ini yaratadi. GURU.Markets platformasidagi narxlar harakati grafigi, bunda ko'rsatkich 0.68 darajasida qayd etilgan, kistik fibrozda oqsil tuzatish uchun DNK terapiyasini ishlab chiqayotgan innovatorning trayektoriyasini aks ettiradi.
%20Kapitallashuvning%20balans%20qiymatiga%20nisbati&width=1200&height=400&colorIndex=0&v=mvujvhid.si-7ayy9s0&start=20220704&end=20261030&filename=GURU_Markets_-_SION_-_Sionna-Therapeutics-Inc_-_Capitalization-to-Book-Value-Ratio "SION: sionnatx.com Bozor qiymatining balans qiymatiga nisbati 08.02.2025 - 30.10.2026 | 👁️GURU.Markets👁️")
Sionna Therapeutics, Inc. (SION) boʻyicha maʼlumotlarning jamlanma tahliliy kesimlari
- bozor qiymati va tahlilchilarning maqsadli prognozi:
- bozor kapitallashuvi ko'rsatkichlari:
- buxgalteriya balansi bo'yicha sof aktivlar qiymati ko'rsatkichlari:
- qarzlar va to'lov qobiliyati haqida ma'lumot:
Qarzning xususiy kapitalga nisbati Sionna Therapeutics Inc|SION - Uzoq muddatli qarzdorlikning kapitalga nisbati|Qisqa muddatli qarzning kapitalga nisbati Sionna Pharma|SION - Kompaniyaning umumiy qarz majburiyatlari|Qarzning balans kapitallashuviga nisbati Sionna Pharma|SION - Uzoq muddatli qarz|Kompaniyaning qisqa muddatli qarzi Sionna Therapeutics|Tezkor likvidlik sionnatx.com
- foyda va bozor multiplikatorlari tafsilotlari:
Kompaniyaning barcha koʻrsatkichlari tahlili:Sionna Therapeutics Inc
Emitentni tanlashda investitsiya risklarini minimallashtirish uchun haddan tashqari qimmat baholangan aktivlarni saralab olib tashlash juda muhimdir. 0.68 ga teng bo'lgan ushbu ko'rsatkich Sionna Therapeutics Inc (SION) bozor qiymatining uning kapitaliga nisbati sifatida hisoblanadi, bunda joriy narx-kitob koeffitsienti biomateriallarni saqlash uchun zarur bo'lgan ixtisoslashtirilgan chuqur muzlatish infratuzilmasi va azot logistikasining real qiymatini baholash imkonini beradi.
Raqobatdosh kompaniyalar tahlili
Tempus Labs (TEM) - Bozor qiymatining balans qiymatiga nisbati|Kapitallashuvning balans qiymatiga nisbati QGEN|IONS (Ionis) - Bozor kapitallashuvining balans qiymatiga nisbati|Kapitallashuvning balans qiymatiga nisbati RGEN (Repligen Corp)|Bozor qiymatining balans qiymatiga nisbati Avidity (RNA)|CRISPR - Kapitallashuvning balans qiymatiga nisbati|Bozor kapitallashuvining balans qiymatiga nisbati WGS (GeneDx Holdings Corp.)|Bozor kapitallashuvining balans qiymatiga nisbati ultragenyx.com RARE|BEAM - Bozor qiymatining balans qiymatiga nisbati|Balans qiymatiga nisbatan bozor kapitallashuvi Sarepta Therapeutics SRPT|TWST: Bozor kapitallashuvining balans qiymatiga nisbati|TXG - Balans qiymatiga nisbatan bozor kapitallashuvi|Bozor qiymatining balans qiymatiga nisbati Intellia Therapeutics|Bozor qiymatining balans qiymatiga koeffitsiyenti stoketherapeutics.com STOK|Bozor qiymatining balans qiymatiga nisbati BioLife Solutions (BLFS)|Wave Life Sciences Ltd - Kapitallashuvning balans qiymatiga nisbati|Bozor qiymatining balans qiymatiga nisbati Maze Tx MAZE|PRME: Kapitallashuvning balans qiymatiga nisbati|Taysha Gene Therapies - Bozor kapitallashuvining balans qiymatiga nisbati|QURE - Bozor kapitallashuvining balans qiymatiga nisbati|MGTX (MeiraGTx) - Kapitallashuvning sof aktivlarga nisbati|REGENXBIO Inc - Balans qiymatiga nisbatan bozor qiymati|Kapitallashuvning sof aktivlarga nisbati SLDB|OCGN (Ocugen Pharma) - Bozor kapitallashuvining balans qiymatiga multiplikatori|Bozor kapitallashuvining balans qiymatiga nisbati PACB|BNTC (benitec.com) - Balans qiymatiga nisbatan bozor qiymati|Bozor kapitallashuvining balans qiymatiga nisbati DSGN (Design Therapeutics, Inc.)|Rocket Pharma (RCKT) - Bozor qiymatining balans qiymatiga koeffitsiyenti|FDMT - Bozor qiymatining balans qiymatiga nisbati|Balans qiymatiga nisbatan bozor qiymati LXEO (Lexeo Therapeutics)|KRRO: Bozor kapitallashuvining balans qiymatiga nisbati|editasmedicine.com (EDIT) - Bozor kapitallashuvining balans qiymatiga nisbati|Bozor qiymatining balans qiymatiga nisbati Silence Therapeutics plc|ProQR Therapeutics NV - Sof aktivlarga nisbatan bozor kapitallashuvi|Bozor kapitallashuvining balans qiymatiga nisbati CDXS|SGMO - Bozor qiymatining balans qiymatiga koeffitsiyenti|Nautilus Bio - Kapitallashuvning sof aktivlarga nisbati|Bozor kapitallashuvining balans qiymatiga nisbati metagenomi.co MGX|DTIL: Kapitallashuvning sof aktivlarga nisbati|Generation Bio Co. - Bozor kapitallashuvining balans qiymatiga multiplikatori|BOLD: Bozor kapitallashuvining balans qiymatiga nisbati|XCUR - Balans qiymatiga nisbatan bozor kapitallashuvi|IMNN (Imunon Inc) - Bozor kapitallashuvining balans qiymatiga nisbati|Kapitallashuvning sof aktivlarga nisbati RXi Pharmaceuticals (PHIO)|Bozor qiymatining balans qiymatiga nisbati Mustang Bio, Inc. (MBIO)|Balans qiymatiga nisbatan bozor kapitallashuvi transcodetherapeutics.com|Bionano Genomics - Kapitallashuvning sof aktivlarga nisbati|Balans qiymatiga nisbatan bozor qiymati APDN|bluebird bio, Inc. - Bozor kapitallashuvining balans qiymatiga nisbati|Balans qiymatiga nisbatan bozor kapitallashuvi ImmunoPrecise Antibodies IPA|Omega Therapeutics, Inc. (OMGA) - Bozor qiymatining balans qiymatiga nisbati|Kapitallashuvning balans qiymatiga nisbati OMIC|RGLS (Regulus Therapeutics Inc) - Bozor kapitallashuvining balans qiymatiga nisbati|Kapitallashuvning sof aktivlarga nisbati Syros Pharmaceuticals, Inc (SYRS)|Bozor qiymatining balans qiymatiga nisbati Telesis Bio, Inc. (TBIO)|Balans qiymatiga nisbatan bozor kapitallashuvi traconpharma.com|Bozor kapitallashuvining balans qiymatiga nisbati UBX (Unity Biotechnology, Inc.)